Epigral to host Bellwether Capital for plant visit in Gujarat
- Epigral Limited hosts Bellwether Capital for a plant visit
- Event scheduled for September 3, 2026 in Dahej, Gujarat
- Disclosure made under SEBI LODR Regulation 30
- No unpublished price-sensitive information to be shared

*this image is generated using AI for illustrative purposes only.
Epigral Limited has scheduled an investor and analyst plant visit for September 3, 2026. The company will host representatives from Bellwether Capital at its manufacturing facility in Dahej, Gujarat.
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Epigral informed the National Stock Exchange of India Limited and BSE Limited on August 31, 2026, regarding the upcoming engagement.
Visit Details
The plant visit is planned for Thursday, September 3, 2026. The location is the Dahej unit in Gujarat. The mode of interaction is an in-person plant visit.
| Detail | Information |
|---|---|
| Investor/Analyst | Bellwether Capital |
| Date | September 3, 2026 |
| Location | Dahej, Gujarat |
| Mode | Plant Visit |
Regulatory Disclosures
Epigral stated that the schedule is subject to change due to exigencies on the part of the analyst, investor, or the company. The firm emphasized that no unpublished price-sensitive information will be shared or discussed during the visit.
Gaurang Trivedi, Company Secretary and Compliance Officer, signed the intimation filed with the exchanges.
Historical Stock Returns for Epigral
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.39% | +6.87% | +2.80% | +34.93% | -33.83% | 0.0% |
How might the insights shared with Bellwether Capital regarding Epigral's Dahej facility impact short-term stock valuation and institutional interest?
What specific capacity expansion or efficiency improvements at the Gujarat plant could be highlighted to justify future growth projections?
Will this engagement signal a broader strategy by Epigral to attract foreign or domestic institutional investors beyond its current shareholder base?


































